Chimeric Mouse Model with
Highly Humanized Liver
Highly Humanized Liver
KMT Hepatech, Inc. is a part of PhoenixBio group since December 1, 2017
KMT Hepatech is a production facility of PhoenixBio Group products (PXB-mouse® and PXB-cells®) in North America.
PhoenixBio Group is utilizing its proprietary platform technology of small animal model of chimeric mouse with highly humanized liver, the PXB-mouse®.
The PXB-mouse® and PXB-cells® are your essential tools for therapeutics and vaccine development.
Commercial scale production of high quality chimeric mice
Always available for shipment
Stable engraftment for entire lifespan
Long-term applications – over 30 days in study
On-demand supply with consistent donor for in vitro reproducibility
Compatible with your preferred format including 3D
News and Events
KMT Hepatech – 20 years
KMT Hepatech – 20 years February marks 20 years since KMT Hepatech (now part of the PhoenixBio Group) was incorporated. It has been a long journey and a great success…
Rare Disease Day: OTCD is a Rare Disease
Rare Disease Day takes place on the last day of February each year since 2008. The main objective of Rare Disease Day is to raise awareness about rare diseases and…
Human hepatocytes – PXB-cells® – in publications
Here we summarize 2020 publications where PXB-cells® were used in such application areas as lipid metabolism, toxicity, drug metabolism and hepatitis B. Hata, K. et al. Biomed. Res. 2020; 41(1):33.…
Non-alcoholic fatty liver-like properties of PXB-cells
We are pleased to share information on PXB-cells NAFL-like properties first reported on PhoenixBio website. The recently published Letter to Editor (“PXB-cells, fresh primary hepatocytes from humanized mouse livers, exhibit…
PXB-cells®: Robust Human Hepatocytes
An open access paper providing a detailed characterization of PXB-cells® was published in late 2020 in PLoS ONE journal. These cells are proven to be a reliable in vitro tool…
KMT Hepatech announces changes in executive management
KMT Hepatech announces changes in executive management Edmonton, December 01, 2020 – KMT Hepatech, Inc. (“KMT”) announced executive management changes. Dr. Norman Kneteman is retired from his position as…